Literature DB >> 20946415

Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain.

J-Y Wang1, H-L Hsu, M-C Yu, C-Y Chiang, F-L Yu, C-J Yu, L-N Lee, P-C Yang.   

Abstract

Patients with pulmonary tuberculosis (TB) can be simultaneously infected with different strains of Mycobacterium tuberculosis (mixed infection). We investigated the prevalence and risk factors of mixed infection by Beijing and non-Beijing strains in pulmonary TB patients in Taiwan. We developed a quantitative PCR method to simultaneously detect the presence of Beijing and non-Beijing strains. A total of 868 pretreatment samples (from 868 patients), including 563 sputum samples smear-positive for acid-fast bacilli and 305 liquid medium samples culture-positive for mycobacteria, were tested. Medical records of patients with culture-confirmed pulmonary TB were reviewed. The detection limit of our quantitative PCR method was five copies of target sequences. With mycobacterial culture result as the reference standard, the sensitivity and specificity of our quantitative PCR method were 95% and 98%, respectively. M. tuberculosis strains were isolated in 466 samples, of which 231 (49.6%) were infected with a Beijing strain. Another 14 patients (3.0%) had mixed infection, with the Beijing strain being the dominant strain in 13 (93%). Age <25 years with pulmonary cavities was associated with mixed infection. In patients infected with non-Beijing strains, the bacterial load of non-Beijing strains was lower among those with mixed infection than among those without. Our quantitative PCR method was accurate in detecting Beijing and non-Beijing strains in smear-positive sputum and culture-positive liquid medium samples. Mixed infection was present in pulmonary TB patients (3.0%), especially in those aged <25 years with pulmonary cavities. Beijing strains seem to be more dominant than non-Beijing strains in patients with mixed infection.
© 2010 The Authors. Clinical Microbiology and Infection © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20946415     DOI: 10.1111/j.1469-0691.2010.03401.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

1.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

2.  Mycobacterium tuberculosis Beijing Genotype in Western Iran: Distribution and Drug Resistance.

Authors:  Parviz Mohajeri; Sakineh Moradi; Sara Atashi; Abbas Farahani
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 3.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 4.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

5.  Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in Botswana.

Authors:  Sanghyuk S Shin; Chawangwa Modongo; Ronald Ncube; Enoch Sepako; Jeffrey D Klausner; Nicola M Zetola
Journal:  J Infect Dis       Date:  2014-07-28       Impact factor: 5.226

6.  Culture-independent detection and characterisation of Mycobacterium tuberculosis and M. africanum in sputum samples using shotgun metagenomics on a benchtop sequencer.

Authors:  Emma L Doughty; Martin J Sergeant; Ifedayo Adetifa; Martin Antonio; Mark J Pallen
Journal:  PeerJ       Date:  2014-09-23       Impact factor: 2.984

7.  Mycobacterium tuberculosis causing tuberculous lymphadenitis in Maputo, Mozambique.

Authors:  Sofia Omar Viegas; Solomon Ghebremichael; Leguesse Massawo; Matos Alberto; Fabíola Couto Fernandes; Eliane Monteiro; David Couvin; José Maiane Matavele; Nalin Rastogi; Margarida Correia-Neves; Adelina Machado; Carla Carrilho; Ramona Groenheit; Gunilla Källenius; Tuija Koivula
Journal:  BMC Microbiol       Date:  2015-11-21       Impact factor: 3.605

8.  SEVERITY OF TB CLASSIFIED BY MODIFIED BANDIM TB SCORING ASSOCIATES WITH THE SPECIFIC SEQUENCE OF ESXA GENES IN MDR-TB PATIENTS.

Authors:  Desak Nyoman Surya Suameitria Dewi; Ni Made Mertaniasih
Journal:  Afr J Infect Dis       Date:  2020-01-08

9.  Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection.

Authors:  Suzanne M Hingley-Wilson; Rosalyn Casey; David Connell; Samuel Bremang; Jason T Evans; Peter M Hawkey; Grace E Smith; Annette Jepson; Stuart Philip; Onn Min Kon; Ajit Lalvani
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.